Tumor suppressor p53 and estrogen receptors in nuclear-mitochondrial communication

Mitochondrion

Volumn 16, Issue , 2014, Pages 26-37

  Wickramasekera, Nadi T ^a   Das, Gokul M ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Breast cancer; Estrogen receptor; Metabolism; Mitochondria; P53

Indexed keywords

ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MITOCHONDRIAL PROTEIN; PROTEIN P53;

AGING; CANCER CELL; CELL COMMUNICATION; CELL DEATH; CELL METABOLISM; CELL NUCLEUS; HUMAN; METABOLIC REGULATION; MITOCHONDRIAL GENOME; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; TRANSCRIPTION REGULATION; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC TRANSCRIPTION; METABOLISM; PHYSIOLOGY;

CELL NUCLEUS; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; MITOCHONDRIA; RECEPTORS, ESTROGEN; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84900541998     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2013.10.002     Document Type: Review

References (153)

1. Achanta G., Sasaki R., Feng L., Carew J.S., Lu W., Pelicano H., Keating M.J., Huang P. Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma. EMBO J. 2005, 24:3482-3492.
2. Ali S., Coombes R.C. Endocrine-responsive breast cancer and strategies for combating resistance. Nat. Rev. Cancer 2002, 2:101-112.
3. Angeloni S.V., Martin M.B., Garcia-Morales P., Castro-Galache M.D., Ferragut J.A., Saceda M. Regulation of estrogen receptor-alpha expression by the tumor suppressor gene p53 in MCF-7 cells. J. Endocrinol. 2004, 180:497-504.
4. Arima Y., Nitta M., Kuninaka S., Zhang D., Fujiwara T., Taya Y., Nakao M., Saya H. Transcriptional blockade induces p53-dependent apoptosis associated with translocation of p53 to mitochondria. J. Biol. Chem. 2005, 280:19166-19176.
5. Bakhanashvili M., Grinberg S., Bonda E., Simon A.J., Moshitch-Moshkovitz S., Rahav G. p53 in mitochondria enhances the accuracy of DNA synthesis. Cell Death Differ. 2008, 15:1865-1874.
6. Barkhem T., Carlsson B., Nilsson Y., Enmark E., Gustafsson J., Nilsson S. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. Mol. Pharmacol. 1998, 54:105-112.
7. Barros R.P., Gustafsson J.A. Estrogen receptors and the metabolic network. Cell Metab. 2011, 14:289-299.
8. Barros R.P., Machado U.F., Warner M., Gustafsson J.A. Muscle GLUT4 regulation by estrogen receptors ERbeta and ERalpha. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:1605-1608.
9. Bayley J.P., Devilee P. The Warburg effect in 2012. Curr. Opin. Oncol. 2012, 24:62-67.
10. Bensaad K., Vousden K.H. p53: new roles in metabolism. Trends Cell Biol. 2007, 17:286-291.
11. Bensaad K., Tsuruta A., Selak M.A., Vidal M.N., Nakano K., Bartrons R., Gottlieb E., Vousden K.H. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006, 126:107-120.
12. Berger C.E., Qian Y., Liu G., Chen H., Chen X. p53, a target of estrogen receptor (ER) alpha, modulates DNA damage-induced growth suppression in ER-positive breast cancer cells. J. Biol. Chem. 2012, 287:30117-30127.
13. Bergh J., Norberg T., Sjogren S., Lindgren A., Holmberg L. Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat. Med. 1995, 1:1029-1034.
14. Berns E.M., Foekens J.A., Vossen R., Look M.P., Devilee P., Henzen-Logmans S.C., van Staveren I.L., van Putten W.L., Inganäs M., Meijer-van Gelder M.E., Cornelisse C., Claassen C.J., Portengen H., Bakker B., Klijn J.G. Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer. Cancer Res. 2000, 60:2155-2162.
15. Bjornholm M., Zierath J.R. Insulin signal transduction in human skeletal muscle: identifying the defects in Type II diabetes. Biochem. Soc. Trans. 2005, 33:354-357.
16. Bourdon A., Minai L., Serre V., Jais J.P., Sarzi E., Aubert S., Chrétien D., de Lonlay P., Paquis-Flucklinger V., Arakawa H., Nakamura Y., Munnich A., Rötig A. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat. Genet. 2007, 39:776-780.
17. Burns D.M., Richter J.D. CPEB regulation of human cellular senescence, energy metabolism, and p53 mRNA translation. Genes Dev. 2008, 22:3449-3460.
18. Cammarata P.R., Chu S., Moor A., Wang Z., Yang S.H., Simpkins J.W. Subcellular distribution of native estrogen receptor alpha and beta subtypes in cultured human lens epithelial cells. Exp. Eye Res. 2004, 78:861-871.
19. Cattoretti G., Rilke F., Andreola S., D'Amato L., Delia D. P53 expression in breast cancer. Int. J. Cancer 1988, 41:178-183.
20. Chang E.C., Charn T.H., Park S.H., Helferich W.G., Komm B., Katzenellenbogen J.A., Katzenellenbogen B.S. Estrogen receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin binding. Mol. Endocrinol. 2008, 22:1032-1043.
21. Chen J.Q., Delannoy M., Cooke C., Yager J.D. Mitochondrial localization of ERalpha and ERbeta in human MCF7 cells. Am. J. Physiol. Endocrinol. Metab. 2004, 286:E1011-E1022.
22. Chen J.Q., Eshete M., Alworth W.L., Yager J.D. Binding of MCF-7 cell mitochondrial proteins and recombinant human estrogen receptors alpha and beta to human mitochondrial DNA estrogen response elements. J. Cell. Biochem. 2004, 93:358-373.
23. Chen D., Yu Z., Zhu Z., Lopez C.D. The p53 pathway promotes efficient mitochondrial DNA base excision repair in colorectal cancer cells. Cancer Res. 2006, 66:3485-3494.
24. Chen J.Q., Cammarata P.R., Baines C.P., Yager J.D. Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications. Biochim. Biophys. Acta 2009, 1793:1540-1570.
25. Cheung E.C., Vousden K.H. The role of p53 in glucose metabolism. Curr. Opin. Cell Biol. 2010, 22:186-191.
26. Chipuk J.E., Green D.R. Dissecting p53-dependent apoptosis. Cell Death Differ. 2006, 13:994-1002.
27. Compton S., Kim C., Griner N.B., Potluri P., Scheffler I.E., Sen S., Jerry D.J., Schneider S., Yadava N. Mitochondrial dysfunction impairs tumor suppressor p53 expression/function. J. Biol. Chem. 2011, 286:20297-20312.
28. Copeland W.C., Ponamarev M.V., Nguyen D., Kunkel T.A., Longley M.J. Mutations in DNA polymerase gamma cause error prone DNA synthesis in human mitochondrial disorders. Acta Biochim. Pol. 2003, 50:155-167.
29. Cowley S.M., Parker M.G. A comparison of transcriptional activation by ER alpha and ER beta. J. Steroid Biochem. Mol. Biol. 1999, 69:165-175.
30. Cowley S.M., Hoare S., Mosselman S., Parker M.G. Estrogen receptors alpha and beta form heterodimers on DNA. J. Biol. Chem. 1997, 272:19858-19862.
31. Cui J., Shen Y., Li R. Estrogen synthesis and signaling pathways during aging: from periphery to brain. Trends Mol. Med. 2013, 19:197-209.
32. D'Assoro A.B., Busby R., Acu I.D., Quatraro C., Reinholz M.M., Farrugia D.J., Schroeder M.A., Allen C., Stivala F., Galanis E., Salisbury J.L. Impaired p53 function leads to centrosome amplification, acquired ERalpha phenotypic heterogeneity and distant metastases in breast cancer MCF-7 xenografts. Oncogene 2008, 27:3901-3911.
33. de Souza-Pinto N.C., Harris C.C., Bohr V.A. p53 functions in the incorporation step in DNA base excision repair in mouse liver mitochondria. Oncogene 2004, 23:6559-6568.
34. De S., Kumari J., Mudgal R., Modi P., Gupta S., Futami K., Goto H., Lindor N.M., Furuichi Y., Mohanty D., Sengupta S. RECQL4 is essential for the transport of p53 to mitochondria in normal human cells in the absence of exogenous stress. J. Cell Sci. 2012, 125:2509-2522.
35. Delaunay F., Pettersson K., Tujague M., Gustafsson J.A. Functional differences between the amino-terminal domains of estrogen receptors alpha and beta. Mol. Pharmacol. 2000, 58:584-590.
36. Diaz-Cruz E.S., Furth P.A. Deregulated estrogen receptor alpha and p53 heterozygosity collaborate in the development of mammary hyperplasia. Cancer Res 2010 May 15, 70(10):3965-3974.
37. Dumont P., Leu J.I., Della Pietra A.C., George D.L., Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat. Genet. 2003, 33:357-365.
38. Duong V., Boulle N., Daujat S., Chauvet J., Bonnet S., Neel H., Cavailles V. Differential regulation of estrogen receptor alpha turnover and transactivation by Mdm2 and stress-inducing agents. Cancer Res. 2007, 67:5513-5521.
39. Dupont S., Mamidi A., Cordenonsi M., Montagner M., Zacchigna L., Adorno M., Martello G., Stinchfield M.J., Soligo S., Morsut L., Inui M., Moro S., Modena N., Argenton F., Newfeld S.J., Piccolo S. FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination. Cell 2009, 136:123-135.
40. Emanuelsson O., Nielsen H., Brunak S., von Heijne G. Predicting subcellular localization of proteins based on their N-terminal amino acid sequence. J. Mol. Biol. 2000, 300:1005-1016.
41. Ferecatu I., Bergeaud M., Rodriguez-Enfedaque A., Le Floch N., Oliver L., Rincheval V., Renaud F., Vallette F.M., Mignotte B., Vayssiere J.L. Mitochondrial localization of the low level p53 protein in proliferative cells. Biochem. Biophys. Res. Commun. 2009, 387:772-777.
42. Folsch H., Guiard B., Neupert W., Stuart R.A. Internal targeting signal of the BCS1 protein: a novel mechanism of import into mitochondria. EMBO J. 1996, 15:479-487.
43. Frank A.K., Pietsch E.C., Dumont P., Tao J., Murphy M.E. Wild-type and mutant p53 proteins interact with mitochondrial caspase-3. Cancer Biol. Ther. 2011, 11:740-745.
44. Fuchs-Young R., Shirley S.H., Lambertz I., Colby J.K., Tian J., Johnston D., Gimenez-Conti I.B., Donehower L.A., Conti C.J., Hursting S.D. P53 genotype as a determinant of ER expression and tamoxifen response in the MMTV-Wnt-1 model of mammary carcinogenesis. Breast Cancer Res. Treat. 2011, 130:399-408.
45. Galluzzi L., Morselli E., Kepp O., Tajeddine N., Kroemer G. Targeting p53 to mitochondria for cancer therapy. Cell Cycle 2008, 7:1949-1955.
46. Gavrilova-Jordan L.P., Price T.M. Actions of steroids in mitochondria. Semin. Reprod. Med. 2007, 25:154-164.
47. Hahne K., Haucke V., Ramage L., Schatz G. Incomplete arrest in the outer membrane sorts NADH-cytochrome b5 reductase to two different submitochondrial compartments. Cell 1994, 79:829-839.
48. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
49. Harris H.A., Bapat A.R., Gonder D.S., Frail D.E. The ligand binding profiles of estrogen receptors alpha and beta are species dependent. Steroids 2002, 67:379-384.
50. Heine P.A., Taylor J.A., Iwamoto G.A., Lubahn D.B., Cooke P.S. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:12729-12734.
51. Heyne K., Mannebach S., Wuertz E., Knaup K.X., Mahyar-Roemer M., Roemer K. Identification of a putative p53 binding sequence within the human mitochondrial genome. FEBS Lett. 2004, 578:198-202.
52. Heyne K., Schmitt K., Mueller D., Armbruester V., Mestres P., Roemer K. Resistance of mitochondrial p53 to dominant inhibition. Mol. Cancer 2008, 7:54.
53. Hu W., Zhang C., Wu R., Sun Y., Levine A., Feng Z. Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:7455-7460.
54. Ibrahim M.M., Razmara M., Nguyen D., Donahue R.J., Wubah J.A., Knudsen T.B. Altered expression of mitochondrial 16S ribosomal RNA in p53-deficient mouse embryos revealed by differential display. Biochim. Biophys. Acta 1998, 1403:254-264.
55. Jackson M.W., Berberich S.J. MdmX protects p53 from Mdm2-mediated degradation. Mol. Cell. Biol. 2000, 20:1001-1007.
56. Jensen E.V. On the mechanism of estrogen action. Perspect. Biol. Med. 1962, 6:47-59.
57. Jensen E.V., Cheng G., Palmieri C., Saji S., Makela S., Van Noorden S., Wahlstrom T., Warner M., Coombes R.C., Gustafsson J.A. Estrogen receptors and proliferation markers in primary and recurrent breast cancer. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:15197-15202.
58. Jensen E.V., Jacobson H.I., Walf A.A., Frye C.A. Estrogen action: a historic perspective on the implications of considering alternative approaches. Physiol. Behav. 2010, 99:151-162.
59. Kaguni L.S. DNA polymerase gamma, the mitochondrial replicase. Annu. Rev. Biochem. 2004, 73:293-320.
60. Katayama H., Sen S. Functional significance of Aurora kinase A regulatory interactions with p53-ERalpha complex in human breast cancer cells. Horm. Cancer 2011, 2:117-124.
61. Khutornenko A.A., Roudko V.V., Chernyak B.V., Vartapetian A.B., Chumakov P.M., Evstafieva A.G. Pyrimidine biosynthesis links mitochondrial respiration to the p53 pathway. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:12828-12833.
62. Klinge C.M. Estrogenic control of mitochondrial function and biogenesis. J. Cell. Biochem. 2008, 105:1342-1351.
63. Ko B.H., Paik J.Y., Jung K.H., Lee K.H. 17Beta-estradiol augments 18F-FDG uptake and glycolysis of T47D breast cancer cells via membrane-initiated rapid PI3K-Akt activation. J. Nucl. Med. 2010, 51:1740-1747.
64. Konduri S.D., Medisetty R., Liu W., Kaipparettu B.A., Srivastava P., Brauch H., Fritz P., Swetzig W.M., Gardner A.E., Khan S.A., Das G.M. Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:15081-15086.
65. Kuiper G.G., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J.A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:5925-5930.
66. Kuiper G.G., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., Gustafsson J.A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997, 138:863-870.
67. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., van der Burg B., Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139:4252-4263.
68. Kulawiec M., Ayyasamy V., Singh K.K. p53 regulates mtDNA copy number and mitocheckpoint pathway. J. Carcinog. 2009, 8:8.
69. Leigh-Brown S., Enriquez J.A., Odom D.T. Nuclear transcription factors in mammalian mitochondria. Genome Biol. 2010, 11:215.
70. Li H., Jogl G. Structural and biochemical studies of TIGAR (TP53-induced glycolysis and apoptosis regulator). J. Biol. Chem. 2009, 284:1748-1754.
71. Liu G., Schwartz J.A., Brooks S.C. Estrogen receptor protects p53 from deactivation by human double minute- 2. Cancer Res. 2000, 60:1810-1814.
72. Liu W., Konduri S.D., Bansal S., Nayak B.K., Rajasekaran S.A., Karuppayil S.M., Rajasekaran A.K., Das G.M. Estrogen receptor-alpha binds p53 tumor suppressor protein directly and represses its function. J. Biol. Chem. 2006, 281:9837-9840.
73. Liu W., Ip M.M., Podgorsak M.B., Das G.M. Disruption of estrogen receptor alpha-p53 interaction in breast tumors: a novel mechanism underlying the anti-tumor effect of radiation therapy. Breast Cancer Res. Treat. 2009, 115:43-50.
74. Lu B., Garrido N., Spelbrink J.N., Suzuki C.K. Tid1 isoforms are mitochondrial DnaJ-like chaperones with unique carboxyl termini that determine cytosolic fate. J. Biol. Chem. 2006, 281:13150-13158.
75. Mahyar-Roemer M., Fritzsche C., Wagner S., Laue M., Roemer K. Mitochondrial p53 levels parallel total p53 levels independent of stress response in human colorectal carcinoma and glioblastoma cells. Oncogene 2004, 23:6226-6236.
76. Mancini F., Di Conza G., Pellegrino M., Rinaldo C., Prodosmo A., Giglio S., D'Agnano I., Florenzano F., Felicioni L., Buttitta F., Marchetti A., Sacchi A., Pontecorvi A., Soddu S., Moretti F. MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway. EMBO J. 2009, 28:1926-1939.
77. Marchenko N.D., Zaika A., Moll U.M. Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J. Biol. Chem. 2000, 275:16202-16212.
78. Marchenko N.D., Wolff S., Erster S., Becker K., Moll U.M. Monoubiquitylation promotes mitochondrial p53 translocation. EMBO J. 2007, 26:923-934.
79. Mathupala S.P., Heese C., Pedersen P.L. Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53. J. Biol. Chem. 1997, 272:22776-22780.
80. Mathupala S.P., Ko Y.H., Pedersen P.L. Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene 2006, 25:4777-4786.
81. Matoba S., Kang J.G., Patino W.D., Wragg A., Boehm M., Gavrilova O., Hurley P.J., Bunz F., Hwang P.M. p53 regulates mitochondrial respiration. Science 2006, 312:1650-1653.
82. Matsuda K., Ochiai I., Nishi M., Kawata M. Colocalization and ligand-dependent discrete distribution of the estrogen receptor (ER)alpha and ERbeta. Mol. Endocrinol. 2002, 16:2215-2230.
83. Mattingly K.A., Ivanova M.M., Riggs K.A., Wickramasinghe N.S., Barch M.J., Klinge C.M. Estradiol stimulates transcription of nuclear respiratory factor-1 and increases mitochondrial biogenesis. Mol. Endocrinol. 2008, 22:609-622.
84. Mauvais-Jarvis F., Clegg D.J., Hevener A.L. The role of estrogens in control of energy balance and glucose homeostasis. Endocr. Rev. 2013, 34:309-338.
85. McDonnell D.P. The molecular determinants of estrogen receptor pharmacology. Maturitas 2004, 48(Suppl. 1):S7-S12.
86. Mercer T.R., Neph S., Dinger M.E., Crawford J., Smith M.A., Shearwood A.M., Haugen E., Bracken C.P., Rackham O., Stamatoyannopoulos J.A., Filipovska A., Mattick J.S. The human mitochondrial transcriptome. Cell 2011, 146:645-658.
87. Mihara K. Targeting and insertion of nuclear-encoded preproteins into the mitochondrial outer membrane. Bioessays 2000, 22:364-371.
88. Mihara M., Moll U.M. Detection of mitochondrial localization of p53. Methods Mol. Biol. 2003, 234:203-209.
89. Mihara M., Erster S., Zaika A., Petrenko O., Chittenden T., Pancoska P., Moll U.M. p53 has a direct apoptogenic role at the mitochondria. Mol. Cell 2003, 11:577-590.
90. Miller L.D., Smeds J., George J., Vega V.B., Vergara L., Ploner A., Pawitan Y., Hall P., Klaar S., Liu E.T., Bergh J. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:13550-13555.
91. Moll U.M., Marchenko N., Zhang X.K. p53 and Nur77/TR3 - transcription factors that directly target mitochondria for cell death induction. Oncogene 2006, 25:4725-4743.
92. Monje P., Boland R. Subcellular distribution of native estrogen receptor alpha and beta isoforms in rabbit uterus and ovary. J. Cell. Biochem. 2001, 82:467-479.
93. Mootha V.K., Bunkenborg J., Olsen J.V., Hjerrild M., Wisniewski J.R., Stahl E., Bolouri M.S., Ray H.N., Sihag S., Kamal M., Patterson N., Lander E.S., Mann M. Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria. Cell 2003, 115:629-640.
94. Moreira P.I., Custodio J., Moreno A., Oliveira C.R., Santos M.S. Tamoxifen and estradiol interact with the flavin mononucleotide site of complex I leading to mitochondrial failure. J. Biol. Chem. 2006, 281:10143-10152.
95. Moreno-Sanchez R., Rodriguez-Enriquez S., Marin-Hernandez A., Saavedra E. Energy metabolism in tumor cells. FEBS J. 2007, 274:1393-1418.
96. Muscolini M., Montagni E., Palermo V., Di Agostino S., Gu W., Abdelmoula-Souissi S., Mazzoni C., Blandino G., Tuosto L. The cancer-associated K351N mutation affects the ubiquitination and the translocation to mitochondria of p53 protein. J. Biol. Chem. 2011, 286:39693-39702.
97. Nemajerova A., Wolff S., Petrenko O., Moll U.M. Viral and cellular oncogenes induce rapid mitochondrial translocation of p53 in primary epithelial and endothelial cells early in apoptosis. FEBS Lett. 2005, 579:6079-6083.
98. Nilsen J., Irwin R.W., Gallaher T.K., Brinton R.D. Estradiol in vivo regulation of brain mitochondrial proteome. J. Neurosci. 2007, 27:14069-14077.
99. Ogawa S., Inoue S., Watanabe T., Orimo A., Hosoi T., Ouchi Y., Muramatsu M. Molecular cloning and characterization of human estrogen rewceptor βcx: a potential inhibitor of estrogen action in human. Nucleic Acids Res. 1998, 3505-3512.
100. Olovnikov I.A., Kravchenko J.E., Chumakov P.M. Homeostatic functions of the p53 tumor suppressor: regulation of energy metabolism and antioxidant defense. Semin. Cancer Biol. 2009, 19:32-41.
101. Osborne C.K., Schiff R. Estrogen-receptor biology: continuing progress and therapeutic implications. J. Clin. Oncol. 2005, 23:1616-1622.
102. Owens K.M., Kulawiec M., Desouki M.M., Vanniarajan A., Singh K.K. Impaired OXPHOS complex III in breast cancer. PLoS One 2011, 6:e23846.
103. Pagliarini D.J., Calvo S.E., Chang B., Sheth S.A., Vafai S.B., Ong S.E., Walford G.A., Sugiana C., Boneh A., Chen W.K., Hill D.E., Vidal M., Evans J.G., Thorburn D.R., Carr S.A., Mootha V.K. A mitochondrial protein compendium elucidates complex I disease biology. Cell 2008, 134:112-123.
104. Parant J., Chavez-Reyes A., Little N.A., Yan W., Reinke V., Jochemsen A.G., Lozano G. Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53. Nat. Genet. 2001, 29:92-95.
105. Pearce S.T., Jordan V.C. The biological role of estrogen receptors alpha and beta in cancer. Crit. Rev. Oncol. Hematol. 2004, 50:3-22.
106. Pedram A., Razandi M., Wallace D.C., Levin E.R. Functional estrogen receptors in the mitochondria of breast cancer cells. Mol. Biol. Cell 2006, 17:2125-2137.
107. Pettersson K., Grandien K., Kuiper G.G., Gustafsson J.A. Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha. Mol. Endocrinol. 1997, 11:1486-1496.
108. Pfanner N., Wiedemann N., Meisinger C., Lithgow T. Assembling the mitochondrial outer membrane. Nat. Struct. Mol. Biol. 2004, 11:1044-1048.
109. Pietsch E.C., Perchiniak E., Canutescu A.A., Wang G., Dunbrack R.L., Murphy M.E. Oligomerization of BAK by p53 utilizes conserved residues of the p53 DNA binding domain. J. Biol. Chem. 2008, 283:21294-21304.
110. Psarra A.M., Sekeris C.E. Steroid and thyroid hormone receptors in mitochondria. IUBMB Life 2008, 60:210-223.
111. Rapaport D. Finding the right organelle. Targeting signals in mitochondrial outer-membrane proteins. EMBO Rep. 2003, 4:948-952.
112. Robey R.B., Hay N. Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene 2006, 25:4683-4696.
113. Roise D., Theiler F., Horvath S.J., Tomich J.M., Richards J.H., Allison D.S., Schatz G. Amphiphilicity is essential for mitochondrial presequence function. EMBO J. 1988, 7:649-653.
114. Rufini A., Tucci P., Celardo I., Melino G. Senescence and aging: the critical roles of p53. Oncogene 2013, 32(43):5129-5143.
115. Sahin E., DePinho R.A. Axis of ageing: telomeres, p53 and mitochondria. Nat. Rev. Mol. Cell Biol. 2012, 13:397-404.
116. Sayan B.S., Sayan A.E., Knight R.A., Melino G., Cohen G.M. p53 is cleaved by caspases generating fragments localizing to mitochondria. J. Biol. Chem. 2006, 281:13566-13573.
117. Sayeed A., Konduri S.D., Liu W., Bansal S., Li F., Das G.M. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis. Cancer Res. 2007, 67:7746-7755.
118. Scarpulla R.C. Nuclear activators and coactivators in mammalian mitochondrial biogenesis. Biochim. Biophys. Acta 2002, 1576:1-14.
119. Schwartzenberg-Bar-Yoseph F., Armoni M., Karnieli E. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res. 2004, 64:2627-2633.
120. Schwend T., Gustafsson J.A. False positives in MALDI-TOF detection of ERbeta in mitochondria. Biochem. Biophys. Res. Commun. 2006, 343:707-711.
121. Shao W., Brown M. Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy. Breast Cancer Res. 2004, 6:39-52.
122. Shirley S.H., Rundhaug J.E., Tian J., Cullinan-Ammann N., Lambertz I., Conti C.J., Fuchs-Young R. Transcriptional regulation of estrogen receptor-alpha by p53 in human breast cancer cells. Cancer Res. 2009, 69:3405-3414.
123. Shvarts A., Steegenga W.T., Riteco N., van Laar T., Dekker P., Bazuine M., van Ham R.C., van der Houven van Oordt W., Hateboer G., van der Eb A.J., Jochemsen A.G. MDMX: a novel p53-binding protein with some functional properties of MDM2. EMBO J. 1996, 15:5349-5357.
124. Skliris G.P., Leygue E., Curtis-Snell L., Watson P.H., Murphy L.C. Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours. Br. J. Cancer 2006, 95:616-626.
125. Stambolsky P., Weisz L., Shats I., Klein Y., Goldfinger N., Oren M., Rotter V. Regulation of AIF expression by p53. Cell Death Differ. 2006, 13:2140-2149.
126. Stirone C., Duckles S.P., Krause D.N., Procaccio V. Estrogen increases mitochondrial efficiency and reduces oxidative stress in cerebral blood vessels. Mol. Pharmacol. 2005, 68:959-965.
127. Stommel J.M., Marchenko N.D., Jimenez G.S., Moll U.M., Hope T.J., Wahl G.M. A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J. 1999, 18:1660-1672.
128. Suzuki S., Tanaka T., Poyurovsky M.V., Nagano H., Mayama T., Ohkubo S., Lokshin M., Hosokawa H., Nakayama T., Suzuki Y., Sugano S., Sato E., Nagao T., Yokote K., Tatsuno I., Prives C. Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:7461-7466.
129. Szczepanek K., Lesnefsky E.J., Larner A.C. Multi-tasking: nuclear transcription factors with novel roles in the mitochondria. Trends Cell Biol. 2012, 22:429-437.
130. Taylor S.W., Fahy E., Zhang B., Glenn G.M., Warnock D.E., Wiley S., Murphy A.N., Gaucher S.P., Capaldi R.A., Gibson B.W., Ghosh S.S. Characterization of the human heart mitochondrial proteome. Nat. Biotechnol. 2003, 21:281-286.
131. Tolstonog G.V., Deppert W. Metabolic sensing by p53: keeping the balance between life and death. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:13193-13194.
132. Trinh D.L., Elwi A.N., Kim S.W. Direct interaction between p53 and Tid1 proteins affects p53 mitochondrial localization and apoptosis. Oncotarget 2010, 1:396-404.
133. Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
134. Vaseva A.V., Marchenko N.D., Ji K., Tsirka S.E., Holzmann S., Moll U.M. p53 opens the mitochondrial permeability transition pore to trigger necrosis. Cell 2012, 149:1536-1548.
135. Vousden K.H. Functions of p53 in metabolism and invasion. Biochem. Soc. Trans. 2009, 37:511-517.
136. Vousden K.H. Alternative fuel-another role for p53 in the regulation of metabolism. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:7117-7118.
137. Vousden K.H., Prives C. Blinded by the light: the growing complexity of p53. Cell 2009, 137:413-431.
138. Wade M., Li Y.C., Wahl G.M. MDM2, MDMX and p53 in oncogenesis and cancer therapy. Nat. Rev. Cancer 2013, 13:83-96.
139. Wallace D.C. A mitochondrial bioenergetic etiology of disease. J. Clin. Invest. 2013, 123:1405-1412.
140. Wang P.Y., Zhuang J., Hwang P.M. p53: exercise capacity and metabolism. Curr. Opin. Oncol. 2012, 24:76-82.
141. Warburg O. On respiratory impairment in cancer cells. Science 1956, 124:269-270.
142. Webster N.J., Resnik J.L., Reichart D.B., Strauss B., Haas M., Seely B.L. Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer. Cancer Res. 1996, 56:2781-2788.
143. Wieckowski M.R., Giorgi C., Lebiedzinska M., Duszynski J., Pinton P. Isolation of mitochondria-associated membranes and mitochondria from animal tissues and cells. Nat. Protoc. 2009, 4:1582-1590.
144. Wong T.S., Rajagopalan S., Freund S.M., Rutherford T.J., Andreeva A., Townsley F.M., Petrovich M., Fersht A.R. Biophysical characterizations of human mitochondrial transcription factor A and its binding to tumor suppressor p53. Nucleic Acids Res. 2009, 37:6765-6783.
145. Yager J.D., Chen J.Q. Mitochondrial estrogen receptors-new insights into specific functions. Trends Endocrinol. Metab. 2007, 18:89-91.
146. Yamashita H., Toyama T., Nishio M., Ando Y., Hamaguchi M., Zhang Z., Kobayashi S., Fujii Y., Iwase H. p53 protein accumulation predicts resistance to endocrine therapy and decreased post-relapse survival in metastatic breast cancer. Breast Cancer Res. 2006, 8:R48.
147. Yang S.H., Liu R., Perez E.J., Wen Y., Stevens S.M., Valencia T., Brun-Zinkernagel A.M., Prokai L., Will Y., Dykens J., Koulen P., Simpkins J.W. Mitochondrial localization of estrogen receptor beta. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:4130-4135.
148. Yang S.H., Prokai L., Simpkins J.W. Correspondence regarding Schwend and Gustafsson, "False positives in MALDI-TOF detection of ERbeta in mitochondria". Biochem. Biophys. Res. Commun. 2006, 345:917-918.
149. Yi P., Bhagat S., Hilf R., Bambara R.A., Muyan M. Differences in the abilities of estrogen receptors to integrate activation functions are critical for subtype-specific transcriptional responses. Mol. Endocrinol. 2002, 16:1810-1827.
150. Yoshida Y., Izumi H., Torigoe T., Ishiguchi H., Itoh H., Kang D., Kohno K. P53 physically interacts with mitochondrial transcription factor A and differentially regulates binding to damaged DNA. Cancer Res. 2003, 63:3729-3734.
151. Zhang G., Yanamala N., Lathrop K.L., Zhang L., Klein-Seetharaman J., Srinivas H. Ligand-independent antiapoptotic function of estrogen receptor-beta in lung cancer cells. Mol. Endocrinol. 2010, 24:1737-1747.
152. Zhao Y., Chaiswing L., Velez J.M., Batinic-Haberle I., Colburn N.H., Oberley T.D., St Clair D.K. p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase. Cancer Res. 2005, 65:3745-3750.
153. Zhou S., Kachhap S., Singh K.K. Mitochondrial impairment in p53-deficient human cancer cells. Mutagenesis 2003, 18:287-292.